Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Gamma in Severe, Congenital Osteopetrosis
NCT00004402Phase 3Completed
- Sponsor
- Food and Drug Administration
- Start
- Nov 1999
- Modality
- Cytokines & Interferons
01
Overview
A Phase 3 trial of interferon gamma-1b in osteopetrosis, sponsored by Food and Drug Administration. Started Nov 1999; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
osteopetrosis
Beyond the preview
Go deeper on NCT00004402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004402.